Cargando…
Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
The case of thiamine‐responsive megaloblastic anemia (TRMA) presented here speculates the need early diagnosis, continuous monitoring, follow‐up, and regulated treatment plan for the patients. Complications and systemic manifestations are likely to enhance in otherwise circumstances.
Autores principales: | Faraji‐Goodarzi, Mojgan, Tarhani, Fariba, Taee, Nadereh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303871/ https://www.ncbi.nlm.nih.gov/pubmed/32577249 http://dx.doi.org/10.1002/ccr3.2791 |
Ejemplares similares
-
Cochlear implant and thiamine-responsive megaloblastic anemia syndrome
por: Hagr, Abdulrahman Abdullah
Publicado: (2014) -
Mermaid Syndrome: A Case Report of a Rare Congenital Anomaly in Full-Term Neonate with Thumb Deformity
por: Taee, Nadereh, et al.
Publicado: (2018) -
Stroke as an Initial Manifestation of Thiamine-Responsive Megaloblastic Anemia
por: Madaan, Priyanka, et al.
Publicado: (2020) -
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment
por: Di Candia, Francesca, et al.
Publicado: (2023) -
Does Early Treatment Prevent Deafness in Thiamine-Responsive Megaloblastic Anaemia Syndrome?
por: Akın, Leyla, et al.
Publicado: (2011)